MOLECULAR MODELING OF 5-HT3 RECEPTOR LIGANDS

被引:31
作者
EVANS, SM [1 ]
GALDES, A [1 ]
GALL, M [1 ]
机构
[1] BOC HEALTHCARE INC, ANAQUEST INC, MURRAY HILL, NJ 07974 USA
关键词
MOLECULAR MODELING; 5-HT3; RECEPTOR; SEROTONIN; PHARMACOPHORE; STRUCTURE-ACTIVITY RELATIONSHIPS; 3-DIMENSIONAL; ANTIEMETIC;
D O I
10.1016/0091-3057(91)90123-J
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Ligands of various chemical classes (e.g., indoles, indazoles, benzamides, carbazoles, and quinolines) have demonstrated high affinity for the 5-HT3 receptor in radiolabeled ligand-binding studies, and have shown 5-HT3 receptor antagonistic activity in functional assays which utilize the excitatory effects of 5-HT on enteric neurons and autonomic afferents. Several 5-HT3 antagonists are currently being evaluated for potential use in the treatment of migraine, schizophrenia, and anxiety, and a few have already demonstrated high efficacy as antiemetics in cancer chemotherapy. The purpose of this presentation is to highlight the significant structure-affinity relationships (SAFIR) and common geometrical features among 5-HT3 receptor ligands, and to describe the three-dimensional pharmacophore for the 5-HT3 recognition site derived from computational techniques. The chemical template containing the recognition elements (functional groups) for the 5-HT3 receptor are: an aromatic or heteroaromatic ring system, a coplanar carbonyl group, and a nitrogen center, interrelated by well-defined distances. Two "binding shapes" or "active shapes" for 5-HT3 ligands have been identified from detailed conformational analyses.
引用
收藏
页码:1033 / 1040
页数:8
相关论文
共 68 条
  • [52] ASSOCIATION OF [H-3] ZACOPRIDE WITH 5-HT3 BINDING-SITES
    PINKUS, LM
    SARBIN, NS
    BAREFOOT, DS
    GORDON, JC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 168 (03) : 355 - 362
  • [53] ANTAGONISM OF [H-3] ZACOPRIDE BINDING TO 5-HT3 RECOGNITION SITES BY ITS (R) AND (S) ENANTIOMERS
    PINKUS, LM
    SARBIN, NS
    GORDON, JC
    MUNSON, HR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 179 (1-2) : 231 - 235
  • [54] LOCALIZATION OF 5-HT3 RECEPTOR-BINDING SITES IN HUMAN DORSAL VAGAL COMPLEX
    REYNOLDS, DJM
    LESLIE, RA
    GRAHAMESMITH, DG
    HARVEY, JM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 174 (01) : 127 - 130
  • [55] AN INITIAL 3-COMPONENT PHARMACOPHORE FOR SPECIFIC SEROTONIN-3 RECEPTOR LIGANDS
    RIZZI, JP
    NAGEL, AA
    ROSEN, T
    MCLEAN, S
    SEEGER, T
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) : 2721 - 2725
  • [56] SYNTHESIS, INVITRO BINDING PROFILE, AND CENTRAL-NERVOUS-SYSTEM PENETRABILITY OF THE HIGHLY POTENT 5-HT3 RECEPTOR ANTAGONIST [H-3] 4-(2-METHOXYPHENYL)-2-[4(5)-METHYL-5(4)-IMIDAZOLYLMETHYL]THIAZOLE
    ROSEN, T
    SEEGER, TF
    MCLEAN, S
    NAGEL, AA
    IVES, JL
    GUARINO, KJ
    BRYCE, D
    FURMAN, J
    ROTH, RW
    CHALABI, PM
    WINDELS, JH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (11) : 3020 - 3023
  • [57] THIAZOLE AS A CARBONYL BIOISOSTERE - A NOVEL CLASS OF HIGHLY POTENT AND SELECTIVE 5-HT3 RECEPTOR ANTAGONISTS
    ROSEN, T
    NAGEL, AA
    RIZZI, JP
    IVES, JL
    DAFFEH, JB
    GANONG, AH
    GUARINO, K
    HEYM, J
    MCLEAN, S
    NOWAKOWSKI, JT
    SCHMIDT, AW
    SEEGER, TF
    SIOK, CJ
    VINCENT, LA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) : 2715 - 2720
  • [58] EMETIC ACTIVITY OF ZACOPRIDE IN FERRETS AND ITS ANTAGONISM BY PHARMACOLOGICAL AGENTS
    SANCILIO, LF
    PINKUS, LM
    JACKSON, CB
    MUNSON, HR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 181 (03) : 303 - 306
  • [59] NEW ANTIEMETIC DRUGS
    SANGER, GJ
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1990, 68 (02) : 314 - 324
  • [60] SCHMIDT AW, 1989, MOL PHARMACOL, V36, P505